ARCA biopharma Announces First Quarter 2023 Financial Results
24 avr. 2023 16h25 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., April 24, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
24 févr. 2023 16h20 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
James Flynn Joins ARCA biopharma Board of Directors
19 déc. 2022 16h05 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that James Flynn has joined its Board of Directors. “We are pleased to welcome James Flynn...
ARCA biopharma Announces Third Quarter 2022 Financial Results
28 oct. 2022 16h15 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Oct. 28, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
ARCA biopharma Announces Second Quarter 2022 Financial Results
02 août 2022 16h15 HE
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Aug. 02, 2022 (GLOBE...
Jacob Ma-Weaver Joins ARCA biopharma Board of Directors
21 juin 2022 16h05 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors. “We are pleased to welcome Jacob...
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
05 mai 2022 16h15 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that it has retained Ladenburg Thalmann & Co. Inc. to act as its financial advisor. In...
ARCA biopharma Announces First Quarter 2022 Financial Results
02 mai 2022 16h15 HE
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., May 02, 2022 (GLOBE...
ARCA biopharma Establishes Special Committee of the Board of Directors
18 avr. 2022 16h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., April 18, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
31 mars 2022 16h15 HE
|
ARCA biopharma, Inc.
For the entire cohort of COVID-19 hospitalized patients, the pooled lower and higher rNAPc2 dose groups demonstrated a reduction compared to baseline in D-dimer levels of 16.8% versus 11.2% for...